Background pattern
NEVANAC 1 mg/ml EYE DROPS, SUSPENSION

NEVANAC 1 mg/ml EYE DROPS, SUSPENSION

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use NEVANAC 1 mg/ml EYE DROPS, SUSPENSION

Introduction

Package Leaflet: Information for the User

NEVANAC 1 mg/ml eye drops, suspension

nepafenac

Read all of this leaflet carefully before you start using this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor, pharmacist, or nurse.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack

  1. What is NEVANAC and what is it used for
  2. What you need to know before you use NEVANAC
  3. How to use NEVANAC
  4. Possible side effects
  5. Storing NEVANAC
  6. Contents of the pack and other information

1. What is NEVANAC and what is it used for

NEVANAC contains the active substance nepafenac which belongs to a group of medicines called non-steroidal anti-inflammatory drugs (NSAIDs).

NEVANAC is used in adults:

To prevent and relieve eye pain and inflammation after cataract surgery in the eye.

To reduce the risk of macular edema (swelling in the back of the eye) after cataract surgery in the eye in diabetic patients.

2. What you need to know before you use NEVANAC

  • if you are allergic to nepafenac or any of the other ingredients of this medicine (listed in section 6),
  • if you are allergic to other non-steroidal anti-inflammatory drugs (NSAIDs)
  • if you have had asthma, skin allergy, or severe nasal inflammation when using other NSAIDs. Examples of NSAIDs are: acetylsalicylic acid, ibuprofen, ketoprofen, piroxicam, and diclofenac.

Warnings and precautions

Consult your doctor, pharmacist, or nurse before starting to use NEVANAC.

  • if you bruise easily or have bleeding problems or have had them in the past.
  • if you have any other eye disorder (e.g. an eye infection) or if you are using other eye medicines (especially eye steroids).
  • if you have diabetes.
  • if you have rheumatoid arthritis.
  • if you have had several eye operations in a short time.

Avoid exposure to sunlight during treatment with NEVANAC.

It is not recommended to wear contact lenses after cataract surgery. Your doctor will tell you when you can start wearing contact lenses again (see also “NEVANAC contains benzalkonium chloride”).

Children and adolescents

Do not use this medicine in children and adolescents under 18 years old as the safety and efficacy in this population have not been established.

Other medicines and NEVANAC

Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines.

NEVANAC may affect or be affected by other medicines you are using, including other eye drops for the treatment of glaucoma.

Tell your doctor if you are using medicines that reduce blood clotting (warfarin) or other NSAIDs. These medicines may increase the risk of bleeding.

Pregnancy and breastfeeding

If you are pregnant or might become pregnant, consult your doctor before using NEVANAC. Women who may become pregnant are advised to use effective contraceptive methods during treatment with NEVANAC. The use of NEVANAC is not recommended during pregnancy. Do not use NEVANAC unless clearly indicated by your doctor.

If you are breastfeeding, NEVANAC may pass into breast milk. However, no effects on the breastfed child are expected. NEVANAC can be used during breastfeeding.

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.

Driving and using machines

Do not drive or use machines until your vision is clear. Immediately after applying NEVANAC, you may notice that your vision becomes blurred.

NEVANAC contains benzalkonium chloride

This medicine contains 0.25 mg of benzalkonium chloride in each 5 ml equivalent to 0.05 mg/ml.

NEVANAC contains a preservative, benzalkonium chloride, which may be absorbed by soft contact lenses and may alter the color of contact lenses. Remove contact lenses before using this medicine and wait 15 minutes before putting them back. Benzalkonium chloride may cause eye irritation, especially if you have dry eyes or other corneal diseases (the transparent layer on the front of the eye). Consult your doctor if you feel any unusual sensation, itching, or pain in the eye after using this medicine.

3. How to use NEVANAC

Follow exactly the instructions of administration of this medicine indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.

Use NEVANAC only in your eyes. Do not swallow or inject.

The recommended dose is

One drop in the affected eye(s), three times a day, morning, noon, and night. Use it at the same time every day.

When to use and for how long

Start 1 day before cataract surgery. Continue on the day of surgery. Then use it for the period of time that your doctor indicates, which may be up to 3 weeks (to prevent and relieve eye pain and inflammation) or 60 days (to prevent macular edema) after your surgery.

How to use

Wash your hands before starting.

Eye with drops being administered by a hand and hand holding an eye drop applicator

  • Shake well before use.
  • Remove the cap from the bottle.
  • After removing the cap, the security seal ring must be removed before using this medicine.
  • Hold the bottle, upside down, between your fingers.
  • Tilt your head back.
  • Gently pull down the lower eyelid to form a pouch (Figure 1).
  • Bring the tip of the bottle close to the eye. You can use a mirror to help.
  • Do not touch the eye, eyelid, or surrounding areas with the dropper because the drops could become contaminated.
  • Gently press the base of the bottle to release one drop of NEVANAC at a time.
  • Do not squeeze the bottle: it is designed to deliver one drop with a gentle pressure on the base (Figure 2).

If you are applying drops to both eyes, repeat the above steps for the other eye. Replace the cap on the bottle immediately after use.

If a drop falls outside the eye, try again.

If you are using other eye drops, wait at least 5 minutes between applying NEVANAC and the other drops.

If you use more NEVANAC than you should

Contact your doctor for detailed instructions. Do not apply more drops until it is time for your next dose.

If you forget to use NEVANAC

Apply a single dose as soon as you remember. If it is almost time for your next dose, do not apply the missed dose. Continue with your regular dosing schedule. Do not use a double dose to make up for missed doses. Do not apply more than one drop 3 times a day in the affected eye(s).

If you stop using NEVANAC

Do not stop using NEVANAC without consulting your doctor. You can usually continue using the eye drops unless the side effects are severe. If these effects worry you, talk to your doctor or pharmacist.

If you have any other questions about using this medicine, ask your doctor, pharmacist, or nurse.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

You may have a higher risk of experiencing corneal side effects (problems on the surface of the eye), if you:

  • have had a complicated eye operation
  • have had several eye operations in a short time
  • have certain conditions affecting the surface of the eye, such as inflammation or dry eyes
  • have certain diseases such as diabetes or rheumatoid arthritis

Contact your doctor immediately if your eyes become red or if the pain increases while using the drops. This may be due to inflammation of the surface of the eye with or without loss or damage to cells or inflammation of the colored part of the eye (iritis). These side effects have been observed in up to 1 in 100 people.

The following side effects have also been observed with NEVANAC 1 mg/ml eye drops, suspension or NEVANAC 3 mg/ml eye drops, suspension or with both:

Uncommon(may affect up to 1 in 100 people)

  • Eye effects:inflammation of the surface of the eye with or without cell damage or loss, feeling of something in the eye, crusts or drooping of the eyelid.

Rare(may affect up to 1 in 1,000 people)

  • Eye effects:inflammation of the iris, eye pain, eye discomfort, dry eyes, eyelid swelling, eye irritation, itching in the eyes, eye discharge, allergic conjunctivitis (eye allergy), increased tearing, deposits on the surface of the eye, fluid accumulation or swelling in the back of the eye, eye redness.
  • General side effects:dizziness, headache, symptoms of allergy (allergic swelling of the eyelids), nausea, itching, redness, and inflammation of the skin.

Frequency not known(frequency cannot be estimated from the available data)

  • Eye effects:damage to the surface of the eye such as thinning or perforation, worsening of eye healing, scarring on the surface of the eye, blurred vision, reduced vision, eye swelling, blurred vision.
  • General side effects:vomiting, increased blood pressure

Reporting of side effects

If you experience any side effects, talk to your doctor, pharmacist, or nurse, even if it is possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storing NEVANAC

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the bottle and carton after EXP. The expiry date is the last day of the month shown.

Do not store above 30°C.

To avoid infections, discard the bottle 4 weeks after first opening. Write the date of opening on the space provided on the bottle label and carton.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.

6. Contents of the pack and other information

  • The active substance is nepafenac. One ml of suspension contains 1 mg of nepafenac.
  • The other ingredients are benzalkonium chloride (see section 2), carbomer, disodium edetate, mannitol, purified water, sodium chloride, and tyloxapol.

Small amounts of sodium hydroxide and/or hydrochloric acid are added to maintain normal acidity levels (pH levels).

Appearance and pack contents

NEVANAC is a liquid (a pale yellow to orange suspension) supplied in a carton containing a 5 ml plastic bottle with a screw cap.

Marketing authorisation holder

Novartis Europharm Limited

Vista Building

Elm Park,

Merrion Road

Dublin 4

Ireland

Manufacturer

Novartis Manufacturing NV

Rijksweg 14

2870 Puurs-Sint-Amands

Belgium

Novartis Pharma GmbH

Roonstrasse 25

90429 Nuremberg

Germany

Novartis Pharma GmbH

Sophie-Germain-Strasse 10

90443 Nürnberg

Germany

You can request more information about this medicine from the local representative of the marketing authorisation holder.

België/Belgique/Belgien

Novartis Pharma N.V.

Tél/Tel: +32 2 246 16 11

Lietuva

SIA Novartis Baltics Lietuvos filialas

Tel: +370 5 269 16 50

Text in Bulgarian language with contact information of Novartis Bulgaria Eood including phone number

Luxembourg/Luxemburg

Novartis Pharma N.V.

Tél/Tel: +32 2 246 16 11

Ceska republika

Novartis s.r.o.

Tel: +420 225 775 111

Magyarország

Novartis Hungária Kft.

Tel.: +36 1 457 65 00

Danmark

Novartis Healthcare A/S

Tlf: +45 39 16 84 00

Malta

Novartis Pharma Services Inc.

Tel: +356 2122 2872

Deutschland

Novartis Pharma GmbH

Tel: +49 911 273 0

Nederland

Novartis Pharma B.V.

Tel: +31 88 04 52 111

Eesti

SIA Novartis Baltics Eesti filiaal

Tel: +372 66 30 810

Norge

Novartis Norge AS

Tlf: +47 23 05 20 00

Text with the company name Novartis (Hellas) A.E.B.E and phone number +30 210 281 17 12

Österreich

Novartis Pharma GmbH

Tel: +43 1 86 6570

España

Novartis Farmacéutica, S.A.

Tel: +34 93 306 42 00

Polska

Novartis Poland Sp. z o.o.

Tel.: +48 22 375 4888

France

Novartis Pharma S.A.S.

Tél: +33 1 55 47 66 00

Portugal

Novartis Farma - Produtos Farmacêuticos, S.A.

Tel: +351 21 000 8600

Hrvatska

Novartis Hrvatska d.o.o.

Tel. +385 1 6274 220

România

Novartis Pharma Services Romania SRL

Tel: +40 21 31299 01

Ireland

Novartis Ireland Limited

Tel: +353 1 260 12 55

Slovenija

Novartis Pharma Services Inc.

Tel: +386 1 300 75 50

Ísland

Vistor hf.

Sími: +354 535 7000

Slovenská republika

Novartis Slovakia s.r.o.

Tel: + 421 2 5542 5439

Italia

Novartis Farma S.p.A.

Tel: +39 02 96 54 1

Suomi/Finland

Novartis Finland Oy

Puh/Tel: +358 (0)10 6133 200

Text with the company name Novartis Pharma Services Inc and phone number +357 22 690 690

Sverige

Novartis Sverige AB

Tel: +46 8 732 32 00

Latvija

SIA “Novartis Baltics”

Tel: +371 67 887 070

Date of last revision of this leaflet:

Other sources of information

Detailed information on this medicine is available on the European Medicines Agency website: http://www.ema.europa.eu

Get updates and exclusive offers

Be the first to know about new services, marketplace updates, and subscriber-only promos.

Follow us on social media
FacebookInstagram
Logo
Oladoctor
Find a doctor
Doctors by specialty
Services
Choose language
© 2025 Oladoctor. All rights reserved.
VisaMastercardStripe